Robert Bruce acquired 250 Thousand Caribou Biosciences shares worth $263 Thousand. That's 0.10% of their equity portfolio (34th largest holding). Robert Bruce started to build up the position in Caribou Biosciences in Q1 2023 and continued to invest until Q2 2024. Since then they sold 50 Thousand shares. The investor's estimated purchase price is $1.16 Million, resulting in a loss of 77%.